By Tony Fong

NEW YORK (GenomeWeb News) – Nearly two weeks after an exclusivity period expired, Affymetrix remains in talks to acquire eBioscience, a company official said today.

Doug Farrell, vice president of investor relations for Affymetrix, told GenomeWeb Daily News that although the exclusivity period for Affy lapsed at the end of the day on March 31, neither firm has canceled the acquisition agreement announced in November, and they remain in ongoing discussions regarding a deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.